Interleukin 8 and cardiovascular disease
Open Access
- 18 July 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 84 (3), 353-360
- https://doi.org/10.1093/cvr/cvp241
Abstract
Since the establishment of the inflammatory basis of atherosclerosis, several pro- or anti-inflammatory agents have been examined as potential mediators of the biochemical pathways of lesion formation. Interleukin (IL)-8 was first characterized in 1987. Since then, knowledge regarding its role in leucocyte trafficking and activation has advanced rapidly, especially in the field of cardiovascular disease. In the scientific literature, there is sufficient evidence to support beyond any doubt the involvement of IL-8 in the establishment and preservation of the inflammatory micro-environment of the insulted vascular wall. However, how the information derived from in vitro studies and animal models can be applied in clinical practice has yet to be determined. In the present review, the available evidence regarding the role of IL-8 in cardiovascular disease is presented, and future perspectives are discussed.Keywords
This publication has 68 references indexed in Scilit:
- Chemokines in Atherosclerosis, Thrombosis, and Vascular BiologyArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitmentProceedings of the National Academy of Sciences of the United States of America, 2008
- Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndromeEuropean Heart Journal, 2008
- Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery diseaseInternational Journal of Cardiology, 2008
- Chemokine regulation of atherosclerosisJournal of Leukocyte Biology, 2007
- High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarctioncclm, 2007
- Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parametersInternational Journal of Obesity, 2006
- Cytokines and cardiovascular diseaseJournal of Leukocyte Biology, 2005
- Structure, Function, and Inhibition of ChemokinesAnnual Review of Pharmacology and Toxicology, 2002
- Interleukin-8 as a sensitive marker of unstable coronary artery diseaseThe American Journal of Cardiology, 1996